TI
NVO

Turner Investments’s Novo Nordisk NVO Stock Holding History

Turner Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,080
Closed -$322K – 347
2015
Q1 		$322K Sell
12,080
-260
-2% -$5.99K 0.06% 270
2014
Q4 		$261K Hold
12,340
– – 0.03% 397
2014
Q3 		$294K Buy
12,340
+3,200
+35% +$73.6K 0.02% 431
2014
Q2 		$211K Sell
9,140
-20
-0.2% -$442 0.01% 496
2014
Q1 		$209K Sell
9,160
-11,040
-55% -$235K 0.01% 558
2013
Q4 		$345K Buy
20,200
+1,900
+10% +$33.1K 0.01% 518
2013
Q3 		$310K Buy
18,300
+1,600
+10% +$26.9K 0.01% 520
2013
Q2 		$259K Buy
+16,700
New +$278K ﹤0.01% 562

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Turner Investments's NVO Position: Q2 2015 in Review

Turner Investments sold out of Novo Nordisk (NVO) in Q2 2015, closing a stake of 12,080 shares — an estimated $322K sold.

Turner Investments first reported a position in NVO in Q2 2013 and held it in 8 quarters. The position peaked at $345K in Q4 2013. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2015.

  • Turner Investments reported no remaining Novo Nordisk position as of Q2 2015 after selling out during the quarter.
  • Turner Investments sold 12,080 Novo Nordisk shares in Q2 2015, an estimated $322K.
  • Turner Investments first reported a position in Novo Nordisk in Q2 2013 and held it in 8 quarters.
  • Turner Investments's Novo Nordisk position peaked at $345K in Q4 2013.
  • 516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2015.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.